Comparison · NCT03017846-4b11824c
Current Study vs NCT02665260: Number of Patients Achieving Complete Lesion Clearance Compared to Prior Study (NCT02665260)
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Current Study vs NCT02665260: Number of Patients Achieving Complete Lesion Clearance Compared to Prior Study (NCT02665260). Trial comparisons, record NCT03017846-4b11824c. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03017846-4b11824c
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.44 | 0.267 | 0.629 | wilson | |
| Risk in group 2 | 0.304 | 0.156 | 0.509 | wilson | |
| Risk difference, group 1 minus group 2 | 0.136 | -0.132 | 0.376 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.45 | 0.676 | 3.09 | log | |
| Odds ratio, group 1 over group 2 | 1.8 | 0.547 | 5.89 | log | |
| Number needed to treat, for one more participant with the outcome on Current Study than on NCT02665260 | 7.37 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Current Study | Subjects with lesions treated with topical cantharidin every 3 weeks up to 12 weeks in the present study.~Cantharidin: Application of topical cantharidin | 11 | 25 | OG000 |
| Group 2 | NCT02665260 | Subjects with lesions treated with topical cantharidin every 3 weeks up to 12 weeks in the previous study NCT02665260.~Cantharidin: Application of topical cantharidin | 7 | 23 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Patients Achieving Complete Lesion Clearance Compared to Prior Study (NCT02665260)
- Description
- Comparison of the number of subjects achieving complete lesion clearance at study completion (up to 12 weeks) to the same measure obtained in our previous study (NCT02665260)
- Time frame
- At study completion, up to 12 weeks
- Population
Source ClinicalTrials.gov
Trial
- Title
- Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2
- NCT number
- NCT03017846
- Phases
- PHASE2
- Conditions
- Molluscum Contagiosum
- Interventions
- Cantharidin
- Lead sponsor
- Steven R Cohen
- Results first posted
- 2019-01-30
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03017846?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03017846-4b11824c